Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine
Authors:
Open Access
- 6 December 2023
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 30 (3) , 360-367
Abstract
No abstract availableKeywords
Funding Information
- NIH
This publication has 17 references indexed in Scilit:
- Emergence of bedaquiline resistance in a high tuberculosis burden countryEuropean Respiratory Journal, 2021
- Treatment outcomes of drug-resistant tuberculosis in people living with HIV in Odesa province, Ukraine, 2014-2016The Journal of Infection in Developing Countries, 2020
- Multidrug-resistant tuberculosis in the Kharkiv Region, UkraineThe International Journal of Tuberculosis and Lung Disease, 2020
- Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective studyBMC Infectious Diseases, 2020
- Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosisThe International Journal of Tuberculosis and Lung Disease, 2019
- Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national surveyThe International Journal of Tuberculosis and Lung Disease, 2018
- Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, UkraineBMC Infectious Diseases, 2017
- Emergence of drug resistance in patients with tuberculosis cared for by the Indian health-care system: a dynamic modelling studyThe Lancet Public Health, 2017
- Management of multi- and extensively drug-resistant tuberculosis in Ukraine: how well are we doing?Public Health Action, 2014
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007